5-hydroxypropafenone has been researched along with dronedarone in 1 studies
| Studies (5-hydroxypropafenone) | Trials (5-hydroxypropafenone) | Recent Studies (post-2010) (5-hydroxypropafenone) | Studies (dronedarone) | Trials (dronedarone) | Recent Studies (post-2010) (dronedarone) |
|---|---|---|---|---|---|
| 59 | 3 | 3 | 507 | 40 | 327 |
| Protein | Taxonomy | 5-hydroxypropafenone (IC50) | dronedarone (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.92 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.6581 | |
| NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | 6.84 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
1 other study(ies) available for 5-hydroxypropafenone and dronedarone
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |